Masimo (NASDAQ:MASI) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

Masimo Co. (NASDAQ:MASI - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $138.22 and traded as high as $169.66. Masimo shares last traded at $168.80, with a volume of 634,326 shares traded.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MASI. Piper Sandler raised their price target on shares of Masimo from $180.00 to $210.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 18th. Wells Fargo & Company raised their target price on shares of Masimo from $171.00 to $193.00 and gave the stock an "overweight" rating in a research report on Wednesday, December 11th. Stifel Nicolaus restated a "buy" rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Raymond James upped their target price on Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a report on Friday, December 27th. Finally, Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Wednesday, November 6th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $179.67.

Masimo Stock Down 1.4 %

The business has a 50 day moving average of $167.68 and a two-hundred day moving average of $138.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The stock has a market capitalization of $8.91 billion, a PE ratio of 114.77 and a beta of 1.01.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. Masimo had a return on equity of 14.98% and a net margin of 3.85%. The company had revenue of $504.60 million during the quarter, compared to analysts' expectations of $502.87 million. During the same period last year, the business posted $0.63 earnings per share. The firm's revenue was up 5.4% compared to the same quarter last year. Analysts predict that Masimo Co. will post 4.03 EPS for the current year.

Institutional Investors Weigh In On Masimo

Several institutional investors and hedge funds have recently made changes to their positions in MASI. Arizona State Retirement System raised its stake in shares of Masimo by 2.0% in the second quarter. Arizona State Retirement System now owns 12,591 shares of the medical equipment provider's stock worth $1,586,000 after purchasing an additional 247 shares during the last quarter. Texas Permanent School Fund Corp increased its stake in shares of Masimo by 12.0% in the second quarter. Texas Permanent School Fund Corp now owns 43,500 shares of the medical equipment provider's stock worth $5,478,000 after acquiring an additional 4,653 shares during the period. Headlands Technologies LLC purchased a new position in shares of Masimo during the second quarter worth $109,000. ClariVest Asset Management LLC acquired a new position in Masimo during the second quarter valued at $1,210,000. Finally, HHM Wealth Advisors LLC grew its position in Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock worth $79,000 after purchasing an additional 125 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.